Fanny Franchini
Fanny Franchini
Verified email at
Cited by
Cited by
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
S Kirchberger, DJ Royston, O Boulard, E Thornton, F Franchini, ...
Journal of Experimental Medicine 210 (5), 917-931, 2013
The short chain fatty acid butyrate imprints an antimicrobial program in macrophages
J Schulthess, S Pandey, M Capitani, KC Rue-Albrecht, I Arnold, ...
Immunity 50 (2), 432-445. e7, 2019
Emerging cytokine networks in colorectal cancer
NR West, S McCuaig, F Franchini, F Powrie
Nature Reviews Immunology 15 (10), 615-629, 2015
Granulocyte macrophage colony-stimulating factor-activated eosinophils promote interleukin-23 driven chronic colitis
T Griseri, IC Arnold, C Pearson, T Krausgruber, C Schiering, F Franchini, ...
Immunity 43 (1), 187-199, 2015
A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages
C Danne, G Ryzhakov, M Martínez-López, NE Ilott, F Franchini, F Cuskin, ...
Cell host & microbe 22 (6), 733-745. e5, 2017
Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis
G Ryzhakov, NR West, F Franchini, S Clare, NE Ilott, SN Sansom, ...
Nature communications 9 (1), 1-13, 2018
An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic
K Degeling, NN Baxter, J Emery, MA Jenkins, F Franchini, P Gibbs, ...
Asia‐Pacific Journal of Clinical Oncology, 2021
FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
JH Im, JN Buzzelli, K Jones, F Franchini, A Gordon-Weeks, B Markelc, ...
Nature communications 11 (1), 1-14, 2020
Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer
W Cui, F Franchini, M Alexander, A Officer, HL Wong, M IJzerman, J Desai, ...
Lung cancer 146, 310-317, 2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
G Chazan, F Franchini, M Alexander, S Banerjee, L Mileshkin, P Blinman, ...
ESMO open 5 (6), e001090, 2020
Assessing the significance of KRAS G12C mutation: Clinicopathologic features, treatments, and survival outcomes in a real-world KRAS mutant non-small cell lung cancer cohort.
W Cui, F Franchini, M Alexander, A Officer, HL Wong, MJ IJzerman, ...
Journal of Clinical Oncology 38 (15_suppl), e19324-e19324, 2020
Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians
G Chazan, F Franchini, M Alexander, S Banerjee, L Mileshkin, P Blinman, ...
ESMO open 6 (5), 100224, 2021
Comparing survival outcomes for advanced cancer patients who access comprehensive genomic sequencing using a registry-based synthetic control arm.
S O Haire, K Degeling, F Franchini, B Tran, SJ Luen, KM Smith, SB Fox, ...
Journal of Clinical Oncology 39 (15_suppl), e18851-e18851, 2021
Do assumptions in health economic evaluations hamper drug uptake?
F Franchini, K Degeling, A Pereira-Salgado, B Tran, G Au-Yeung, ...
Journal of Clinical Oncology 38 (15_suppl), e19289-e19289, 2020
A Crispr Knockout Screen Identifies Foxf1 as a Suppressor of Colorectal Cancer Metastasis that Acts through Reduced mTOR Signalling
L Lee, C Woolley, T Starkey, L Freeman-Mills, A Bassett, F Franchini, ...
bioRxiv, 613356, 2019
Immune regulatory networks in inflammation-driven cancer
F Franchini
University of Oxford, 2017
Dysregulated repair processes in inflammation and colorectal cancer: pathogenic regulatory T cells to blame?
F Franchini, N West, DJ Royston, FM Powrie
Neue Erkenntnisse zur Rolle der Mikrobiota im kolorektalen Karzinom
S Zeissig, J Hampe
Zeitschrift für Gastroenterologie 54 (05), 406-408, 2016
The system can't perform the operation now. Try again later.
Articles 1–18